IBDEI0K2 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27037,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,27037,2)
 ;;=Open Angle Glaucoma Suspect^268747
 ;;^UTILITY(U,$J,358.3,27038,0)
 ;;=365.04^^186^1705^37
 ;;^UTILITY(U,$J,358.3,27038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27038,1,3,0)
 ;;=3^Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,27038,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,27038,2)
 ;;=Ocular Hypertension^85124
 ;;^UTILITY(U,$J,358.3,27039,0)
 ;;=365.03^^186^1705^44
 ;;^UTILITY(U,$J,358.3,27039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27039,1,3,0)
 ;;=3^Steroid Responder
 ;;^UTILITY(U,$J,358.3,27039,1,4,0)
 ;;=4^365.03
 ;;^UTILITY(U,$J,358.3,27039,2)
 ;;=^268749
 ;;^UTILITY(U,$J,358.3,27040,0)
 ;;=366.11^^186^1705^41
 ;;^UTILITY(U,$J,358.3,27040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27040,1,3,0)
 ;;=3^Pseudoexfoliation w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,27040,1,4,0)
 ;;=4^366.11
 ;;^UTILITY(U,$J,358.3,27040,2)
 ;;=^265538
 ;;^UTILITY(U,$J,358.3,27041,0)
 ;;=365.02^^186^1705^1
 ;;^UTILITY(U,$J,358.3,27041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27041,1,3,0)
 ;;=3^Anatomic Narrow Angle
 ;;^UTILITY(U,$J,358.3,27041,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,27041,2)
 ;;=Anatomic Narrow Angle^268748
 ;;^UTILITY(U,$J,358.3,27042,0)
 ;;=364.53^^186^1705^39
 ;;^UTILITY(U,$J,358.3,27042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27042,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,27042,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,27042,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,27043,0)
 ;;=364.42^^186^1705^42
 ;;^UTILITY(U,$J,358.3,27043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27043,1,3,0)
 ;;=3^Rubeosis Iridis w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,27043,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,27043,2)
 ;;=Rubeosis Iridis w/o Glaucoma^268716
 ;;^UTILITY(U,$J,358.3,27044,0)
 ;;=364.77^^186^1705^2
 ;;^UTILITY(U,$J,358.3,27044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27044,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,27044,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,27044,2)
 ;;=Angle Recession w/o Glauc^268743
 ;;^UTILITY(U,$J,358.3,27045,0)
 ;;=368.40^^186^1705^45
 ;;^UTILITY(U,$J,358.3,27045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27045,1,3,0)
 ;;=3^Visual Field Defect
 ;;^UTILITY(U,$J,358.3,27045,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,27045,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,27046,0)
 ;;=363.70^^186^1705^4
 ;;^UTILITY(U,$J,358.3,27046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27046,1,3,0)
 ;;=3^Choroidal Detachment NOS
 ;;^UTILITY(U,$J,358.3,27046,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,27046,2)
 ;;=^276841
 ;;^UTILITY(U,$J,358.3,27047,0)
 ;;=365.24^^186^1705^28
 ;;^UTILITY(U,$J,358.3,27047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27047,1,3,0)
 ;;=3^Glaucoma,Residual Angle Closure
 ;;^UTILITY(U,$J,358.3,27047,1,4,0)
 ;;=4^365.24
 ;;^UTILITY(U,$J,358.3,27047,2)
 ;;=^268758
 ;;^UTILITY(U,$J,358.3,27048,0)
 ;;=365.65^^186^1705^34
 ;;^UTILITY(U,$J,358.3,27048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27048,1,3,0)
 ;;=3^Glaucoma,Traumatic
 ;;^UTILITY(U,$J,358.3,27048,1,4,0)
 ;;=4^365.65
 ;;^UTILITY(U,$J,358.3,27048,2)
 ;;=^268780
 ;;^UTILITY(U,$J,358.3,27049,0)
 ;;=365.89^^186^1705^23
 ;;^UTILITY(U,$J,358.3,27049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27049,1,3,0)
 ;;=3^Glaucoma,Oth Specified
 ;;^UTILITY(U,$J,358.3,27049,1,4,0)
 ;;=4^365.89
 ;;^UTILITY(U,$J,358.3,27049,2)
 ;;=^88069
 ;;^UTILITY(U,$J,358.3,27050,0)
 ;;=365.05^^186^1705^38
 ;;^UTILITY(U,$J,358.3,27050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27050,1,3,0)
 ;;=3^Opn Ang w/ brdrlne fnd-Hi Risk
 ;;^UTILITY(U,$J,358.3,27050,1,4,0)
 ;;=4^365.05
 ;;^UTILITY(U,$J,358.3,27050,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,27051,0)
 ;;=365.06^^186^1705^40
 ;;^UTILITY(U,$J,358.3,27051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27051,1,3,0)
 ;;=3^Prim Ang Clos w/o Glauc Dmg
 ;;^UTILITY(U,$J,358.3,27051,1,4,0)
 ;;=4^365.06
 ;;^UTILITY(U,$J,358.3,27051,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,27052,0)
 ;;=365.70^^186^1705^31
 ;;^UTILITY(U,$J,358.3,27052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27052,1,3,0)
 ;;=3^Glaucoma,Stage NOS
 ;;^UTILITY(U,$J,358.3,27052,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,27052,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,27053,0)
 ;;=365.71^^186^1705^17
 ;;^UTILITY(U,$J,358.3,27053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27053,1,3,0)
 ;;=3^Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,27053,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,27053,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,27054,0)
 ;;=365.72^^186^1705^18
 ;;^UTILITY(U,$J,358.3,27054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27054,1,3,0)
 ;;=3^Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,27054,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,27054,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,27055,0)
 ;;=365.73^^186^1705^30
 ;;^UTILITY(U,$J,358.3,27055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27055,1,3,0)
 ;;=3^Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,27055,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,27055,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,27056,0)
 ;;=365.74^^186^1705^14
 ;;^UTILITY(U,$J,358.3,27056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27056,1,3,0)
 ;;=3^Glaucoma,Indeterm Stage
 ;;^UTILITY(U,$J,358.3,27056,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,27056,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,27057,0)
 ;;=V19.11^^186^1705^5
 ;;^UTILITY(U,$J,358.3,27057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27057,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,27057,1,4,0)
 ;;=4^V19.11
 ;;^UTILITY(U,$J,358.3,27057,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,27058,0)
 ;;=V19.19^^186^1705^6
 ;;^UTILITY(U,$J,358.3,27058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27058,1,3,0)
 ;;=3^Family Hx Oth Spec Eye Disord
 ;;^UTILITY(U,$J,358.3,27058,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,27058,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,27059,0)
 ;;=365.62^^186^1705^8
 ;;^UTILITY(U,$J,358.3,27059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27059,1,3,0)
 ;;=3^Glauc Assoc w/ Ocular Inflamm
 ;;^UTILITY(U,$J,358.3,27059,1,4,0)
 ;;=4^365.62
 ;;^UTILITY(U,$J,358.3,27059,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,27060,0)
 ;;=365.00^^186^1705^33
 ;;^UTILITY(U,$J,358.3,27060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27060,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,27060,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,27060,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,27061,0)
 ;;=365.60^^186^1705^10
 ;;^UTILITY(U,$J,358.3,27061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27061,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,27061,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,27061,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,27062,0)
 ;;=365.9^^186^1705^35
 ;;^UTILITY(U,$J,358.3,27062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27062,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,27062,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,27062,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,27063,0)
 ;;=365.22^^186^1705^12
 ;;^UTILITY(U,$J,358.3,27063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27063,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,27063,1,4,0)
 ;;=4^365.22
 ;;^UTILITY(U,$J,358.3,27063,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,27064,0)
 ;;=365.59^^186^1705^7
 ;;^UTILITY(U,$J,358.3,27064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27064,1,3,0)
 ;;=3^Glauc Assoc w/ Lens D/O
 ;;^UTILITY(U,$J,358.3,27064,1,4,0)
 ;;=4^365.59
 ;;^UTILITY(U,$J,358.3,27064,2)
 ;;=^268773
 ;;^UTILITY(U,$J,358.3,27065,0)
 ;;=365.44^^186^1705^9
 ;;^UTILITY(U,$J,358.3,27065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27065,1,3,0)
 ;;=3^Glauc Assoc w/ Systemic Syndromes
 ;;^UTILITY(U,$J,358.3,27065,1,4,0)
 ;;=4^365.44
 ;;^UTILITY(U,$J,358.3,27065,2)
 ;;=^268769
 ;;^UTILITY(U,$J,358.3,27066,0)
 ;;=377.14^^186^1705^36
 ;;^UTILITY(U,$J,358.3,27066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27066,1,3,0)
 ;;=3^Glaucomatous Atrophy
 ;;^UTILITY(U,$J,358.3,27066,1,4,0)
 ;;=4^377.14
 ;;^UTILITY(U,$J,358.3,27066,2)
 ;;=^269218
 ;;^UTILITY(U,$J,358.3,27067,0)
 ;;=365.14^^186^1705^15
 ;;^UTILITY(U,$J,358.3,27067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27067,1,3,0)
 ;;=3^Glaucoma,Infantile/Juv
 ;;^UTILITY(U,$J,358.3,27067,1,4,0)
 ;;=4^365.14
 ;;^UTILITY(U,$J,358.3,27067,2)
 ;;=^268750
 ;;^UTILITY(U,$J,358.3,27068,0)
 ;;=743.20^^186^1705^3
 ;;^UTILITY(U,$J,358.3,27068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27068,1,3,0)
 ;;=3^Buphthalmous,Unsp w/ Oth Ocu Abnormal
 ;;^UTILITY(U,$J,358.3,27068,1,4,0)
 ;;=4^743.20
 ;;^UTILITY(U,$J,358.3,27068,2)
 ;;=^59682
 ;;^UTILITY(U,$J,358.3,27069,0)
 ;;=378.83^^186^1706^3
 ;;^UTILITY(U,$J,358.3,27069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27069,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,27069,1,4,0)
 ;;=4^378.83
 ;;^UTILITY(U,$J,358.3,27069,2)
 ;;=Convergence Insufficiency^269277
 ;;^UTILITY(U,$J,358.3,27070,0)
 ;;=378.00^^186^1706^5
 ;;^UTILITY(U,$J,358.3,27070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27070,1,3,0)
 ;;=3^Esotropia
 ;;^UTILITY(U,$J,358.3,27070,1,4,0)
 ;;=4^378.00
 ;;^UTILITY(U,$J,358.3,27070,2)
 ;;=Esotropia^42597
 ;;^UTILITY(U,$J,358.3,27071,0)
 ;;=378.10^^186^1706^9
 ;;^UTILITY(U,$J,358.3,27071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27071,1,3,0)
 ;;=3^Exotropia
 ;;^UTILITY(U,$J,358.3,27071,1,4,0)
 ;;=4^378.10
 ;;^UTILITY(U,$J,358.3,27071,2)
 ;;=Exotropia^43741
 ;;^UTILITY(U,$J,358.3,27072,0)
 ;;=378.41^^186^1706^4
 ;;^UTILITY(U,$J,358.3,27072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27072,1,3,0)
 ;;=3^Esophoria
 ;;^UTILITY(U,$J,358.3,27072,1,4,0)
 ;;=4^378.41
 ;;^UTILITY(U,$J,358.3,27072,2)
 ;;=Esophoria^265435
 ;;^UTILITY(U,$J,358.3,27073,0)
 ;;=378.42^^186^1706^8
 ;;^UTILITY(U,$J,358.3,27073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27073,1,3,0)
 ;;=3^Exophoria
 ;;^UTILITY(U,$J,358.3,27073,1,4,0)
 ;;=4^378.42
